Effect of adipose-derived mesenchymal stem cell transplantation on inflammatory response and ventricular remodeling after myocardial infarction

Chinese Journal of Tissue Engineering Research

Volumn 18, Issue 6, 2014, Pages 900-905

  Fan, Yan ^a   Wang, Jian Jun ^b   Wei, Feng ^a   Fan, Xiao Hai ^c   Ma, Ai Qun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b Department of Orthopedics The First People's Hospital of Lanzhou ^*  (China)

^c LANZHOU GENERAL HOSPITAL   (China)

Author keywords

Abdominal fat; Cell transplantation; Cytokines; Mesenchymal stem cells; Myocardial infarction; Stem cells; Ventricular remodeling

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIPOSE DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT;

EID: 84907910476     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.2095-4344.2014.06.013     Document Type: Article

References (35)

1. Tang J, Xie Q, Pan G, et al. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. J Eur J Cardiothorac Surg. 2006; 30(2): 353-361.
2. Joshua M, Jay H, Timothy D, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Journal of the American College of Cardiology. 2009; 54(24): 2277-2286.
3. Blatt A, Minha S, Moravsky G, et al. Intracoronary administration of autologous bone marrow mononuclear cells in patients with chronic ischemic symptomatic cardiomyopathy: 5 years follow-up. Isr Med Assoc J. 2010; 12(12): 738-741.
4. Bartunek J, Sherman W, Vanderheyden M, et al. Delivery of biologics in cardiovascular regenerative medicine. J Clin Pharmacol Ther. 2009; 85(5): 548-552.
5. Enoki C, Otani H, Sato D, et al. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction. Int J Cardiol. 2010; 138(1): 9-18.
6. Numata A, Miyauchi Y, Ono N, et al. Spontaneous Atrial Fibrillation Initiated by Tyramine in Canine Atria with Increased Sympathetic Nerve Sprouting. J Cardiovasc Electrophysiol. 2012; 23(4): 415-422.
7. Okura H, Matsuyama A, Lee CM, et al. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng Part C Methods. 2010; 16(3): 417-425.
8. Jaremo P, Nilsson O. Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction. Eur J Intern Med. 2008; 19(5): 330-333.
9. Anzai T. Post-infarction inflammation and left ventricular remodeling: a double-edged sword. J Circ. 2013; 77(3): 580-587.
10. Shantsila E, Tapp L D, Wrigley B J, et al. Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction. J Thromb Haemost. 2013; 109(2): 255-262.
11. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. J Nat Rev Immunol. 2010; 10(12): 826-837.
12. Ammirati E, Cannistraci CV, Cristell NA, et al. Aification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6-interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction. Circ Res. 2012; 111(10): 1336-1348.
13. Hofmann U, Frantz S. How can we cure a heart "in flame"? A translational view on inflammation in heart failure. Basic Res Cardiol. 2013; 108(4): 356.
14. Mann DL. argeted anticytokine therapy and the failing heart. Am J Cardiol. 2005; 95(11A): 9C-16C.
15. Akiyama K, Chen C, Wang D, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012; 10(5): 544-555.
16. Matysiak M, Orlowski W, Fortak-Michalska M, et al. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J Neuroimmunol. 2011; 233(1-2): 106-111.
17. Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010; 466(7308): 829-834.
18. Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood. 2005; 105(5): 2214-2219.
19. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002; 30(1): 42-48.
20. Fong CY, Chak LL, Biswas A, et al. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. 2011; 7(1): 1-16.
21. Ning HM, Jin JG, Hu JW, et al. Effect of human bone marrow mesenchymal stem cell on allogeneic T lymphocyte phenotype in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005; 13(1): 43-49.
22. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012; 20(1): 14-20.
23. Franquesa M, Hoogduijn MJ, Baan CC. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance. Curr Opin Organ Transplant. 2012; 17(4): 355-361.
24. Gottumukkala RV, Lv H, Cornivelli L, et al. cardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes. Sci Transl Med. 2012; 4(138): 138ra80.
25. Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res. 2011; 108(9): 1122-132.
26. Nabeebaccus A, Zhang M, Shah AM. NADPH oxidases and cardiac remodelling. Heart Fail Rev. 2011; 16(1): 5-12.
27. Westermann D, Becher PM, Lindner D, et al. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo. Basic Res Cardiol. 2012; 107(6): 308.
28. Dupont M, Tang WH. Right ventricular afterload and the role of nitric oxide metabolism in left-sided heart failure. J Card Fail. 2013; 19(10): 712-721.
29. Bradham WS, Bozkurt B, Gunasinghe H, et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res. 2002; 53(4): 822-830.
30. Yang Z, Zingarelli B, Szabó C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation. 2000; 101(9): 1019-1026.
31. Ouyang W, Rutz S, Crellin NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011; 29: 71-109.
32. Choi H, Lee RH, Bazhanov N, et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood. 2011; 118(2): 330-338.
33. Roddy GW, Oh JY, Lee RH, et al. Action at a distance: systemically administered adult stem/progenitor cells(MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. J Stem Cells. 2011; 29(10): 1572-1579.
34. Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. J Cell Stem. 2009; 5(1): 54-63.
35. Nemeth K, Leelahavaniehkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogrammingof host macrophages to increase their interleukin-10 production. J Nat Med. 2009; 15(1): 42-49.